Methylation status of the long control region of HPV 16 in clinical cervical specimens

Molecular Medicine Reports

Volumn 1, Issue 4, 2008, Pages 555-560

  Hong, Die ^a   Ye, Feng ^a   Lu, Weiguo ^a   Hu, Ying ^a   Wan, Xiaoyun ^a   Chen, Yaxia ^a   Xie, Xing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cervical carcinoma; Cervical intraepithelial neoplasia; Human papillomavirus; Long control region; Methylation; Pyrosequencing

Indexed keywords

BISULFITE;

ARTICLE; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; DNA MODIFICATION; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; LONG CONTROL REGION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PYROSEQUENCING; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 69249097032     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.4.555     Document Type: Article

References (31)

1. Fuks F: DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 15: 490-495, 2005.
2. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21, 2002. (Pubitemid 34049633)
3. Doerfler W: On the biological significance of DNA methylation. Biochemistry 70: 505-524, 2005.
4. Mino A, Onoda N, Yashiro M, et al: Frequent p16 CpG island hypermethylation in primary remnant gastric cancer suggesting an independent carcinogenic pathway. Oncol Rep 15: 615-620, 2006.
5. Zhu WG, Srinivasan K, Dai Z, et al: Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol 23: 4056-4065, 2003. (Pubitemid 36666412)
6. Kim K, Garner-Hamrick PA, Fisher C, Lee D and Lambert PF: Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77: 12450-12459, 2003. (Pubitemid 37430642)
7. Thain A, Jenkins O, Clarke AR and Gaston K: CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 70: 7233-7235, 1996. (Pubitemid 26307443)
8. List HJ, Patzel V, Zeidler U, et al: Methylation sensitivity of the enhancer from the human papillomavirus type 16. J Biol Chem 269: 11902-11911, 1994. (Pubitemid 24196679)
9. Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA, et al: Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 120: 2165-2169, 2007. (Pubitemid 46555853)
10. Munger K, Baldwin A, Edwards KM, et al: Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78: 11451-11460, 2004.
11. Cripe TP, Haugen TH, Turk JP, et al: Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 transactivator and repressor gene products: implications for cervical carcinogenesis. EMBO J 6: 3745-3753, 1987.
12. Cripe TP, Alderborn A, Anderson RD, et al: Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. New Biol 2: 450-463, 1990. (Pubitemid 20235658)
13. Dostatni N, Lambert PF, Sousa R, Ham J, Howley PM and Yaniv M: The functional BPV-1 E2 transactivating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev 5: 1657-1671, 1991. (Pubitemid 21906070)
14. Tan SH, Gloss B and Bernard HU: During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res 20: 251-256, 1992.
15. Turek LP: The structure, function, and regulation of papillomaviral genes in infection and cervical cancer. Adv Virus Res 44: 305-356, 1994.
16. Bouvard V, Storey A, Pim D and Banks L: Characterization of the human papillomavirus E2 protein: evidence of transactivation and transrepression in cervical keratinocytes. EMBO J 13: 5451-5459, 1994. (Pubitemid 24351824)
17. Lambert PF, Dostatni N, McBride AA, Yaniv M, Howley PM and Arcangioli B: Functional analysis of the papilloma virus E2 transactivator in Saccharomyces cerevisiae. Genes Dev 3: 38-48, 1989.
18. Badal V, Chuang LS, Tan EH, et al: CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77: 6227-6234, 2003. (Pubitemid 36588393)
19. Kalantari M, Calleja-Macias IE, Tewari D, et al: Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 78: 12762-12772, 2004. (Pubitemid 39507784)
20. Alderborn A, Kristofferson A and Hammerling U: Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res 10: 1249-1258, 2000. (Pubitemid 30702300)
21. Wong HL, Byun HM, Kwan JM, et al: Rapid and quantitative method of allele-specific DNA methylation analysis. Biotechniques 41: 734-739, 2006. (Pubitemid 46534859)
22. Dupont JM, Tost J, Jammes H and Gut IG: De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 333: 119-127, 2004.
23. Hong D, Ye F, Chen H, et al: Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. Int J Gynecol Cancer 18: 104-109, 2008.
24. Grunau C, Clark SJ and Rosenthal A: Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 29: E65-E65, 2001.
25. Rajeevan MS, Swan DC, Duncan K, Lee DR, Limor JR and Unger ER: Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J Virol Methods 138: 170-176, 2006. (Pubitemid 44633461)
26. Turan T, Kalantari M, Calleja-Macias IE, et al: Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology 349: 175-183, 2006.
27. Galagan JE and Selker EU: RIP: the evolutionary cost of genome defense. Trends Genet 20: 417-423, 2004.
28. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT and Broker TR: Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Human Pathol 23: 117-128, 1992.
29. Furumoto H and Irahara M: Human papilloma virus (HPV) and cervical cancer. J Med Invest 49: 124-133, 2002. (Pubitemid 35452968)
30. Rajeevan MS, Swan DC, Nisenbaum R, et al: Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer 115: 114-120, 2005. (Pubitemid 40559675)
31. Verma M: Viral genes and methylation. Ann NY Acad Sci 983: 170-180, 2003.